About Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome
Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome is a rare disease catalogued by Orphanet (ORPHA:477673). It is associated with the GPT2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome trials.
Search ClinicalTrials.gov for "Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome" or filter by Orphanet code ORPHA:477673 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome. Updated daily.